Pharmacoeconomics of Genetically Engineered Drugs
- 1 January 1992
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 1 (1) , 45-53
- https://doi.org/10.2165/00019053-199201010-00009
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Medical costs of coronary artery disease in the United StatesThe American Journal of Cardiology, 1990
- Hospital charges and reimbursement for alteplase and streptokinaseAmerican Journal of Health-System Pharmacy, 1990
- Economics of epoetin therapy.1989
- Colony-stimulating factors and tomorrow's pharmacy: why we must be ready.1989
- Biologic response modifiers: The interferon alfa experienceAmerican Journal of Health-System Pharmacy, 1989
- Recombinant human erythropoietin.1989
- Cost-Benefit Analysis of Interferon Alfa-2b in Treatment of Hairy Cell LeukemiaJNCI Journal of the National Cancer Institute, 1989
- Malignant melanoma: cost and reimbursement issues.1989
- Drug-Use Evaluation of Thrombolytic Agents: A Challenge to PharmacistsAmerican Journal of Health-System Pharmacy, 1988
- National health expenditures, 1986-20001987